| Schedule of shares issued |
| | | | | | | | Number of | | | Common Shares | | Shares | | Stated Value | Balance at September 30, 2023 | | 19,008,425 | | $ | 17,864,782 | Purchase of shares for cancellation | | (950,417) | | | (938,924) | Exercise of options | | 213,703 | | | 330,810 | Balance at September 30, 2024 | | 18,271,711 | | $ | 17,256,668 | Shares issued for acquisitions | | 1,283,849 | | | 22,330,215 | Conversions of Notes into common shares | | 1,147,806 | | | 13,247,405 | Exercise of options | | 1,698,476 | | | 3,120,672 | Exercise of warrants | | 452,333 | | | 11,219,562 | Exercise of RSUs | | 124,103 | | | 2,882,142 | Interest paid with common shares | | 21,563 | | | 371,891 | Balance at September 30, 2025 | | 22,999,841 | | $ | 70,428,555 |
|
| Schedule of basic and diluted earnings per share |
| | | | | | | Year ended September 30, | | 2025 | | 2024 | Net income for the period | | $ | (35,035,126) | | $ | 6,607,664 | Weighted average number of shares outstanding | | | 20,092,474 | | | 18,648,420 | Earnings per share, basic | | $ | (1.74) | | $ | 0.35 | | | | | | | | Weighted average number of shares outstanding | | | 20,092,474 | | | 18,648,420 | Share based compensation dilution | | | — | | | 100,185 | Weighted average number of shares outstanding, diluted | | | 20,092,474 | | | 18,748,605 | Earnings per share, diluted | | $ | (1.74) | | $ | 0.35 |
|